CSD500 Update

RNS Number : 5118G

Futura Medical PLC

02 February 2010

 



For immediate release

2nd February 2010

 

Futura Medical plc

("Futura" or "the Company")

 CSD500 Update

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces an update on progress towards the marketing authorisation of its lead product, CSD500, which is scheduled to be launched as a Durex®-branded condom by SSL International plc (SSL).

Data is still being collected however the initial validation of the changes made to improve the manufacturing process has now been completed and accordingly Futura and SSL are currently updating the regulatory dossier necessary for CE Mark approval.  Futura anticipates that SSL will submit the dossier to the relevant Notified Body in March 2010.

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
Nomura Code Securities Limited
Phil Walker / Giles Balleny	Tel:[phone]
For media enquiries please contact:
Buchanan Communications
Mark Court / Stasa Filiplic / Jennie Spivey	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

MSCUUUVRRVAURRR